BACKGROUND: Daily life motor skills of children with acute lymphoblastic leukemia (ALL) were studied during treatment using the Movement Assessment Battery for Children (Movement ABC). In addition, the possible relation with vincristine treatment was investigated. PROCEDURE: Seventeen children treated for ALL, aged 4-12 years, were compared to an age- and sex-matched control group. RESULTS: The leukemia group performed more poorly than the control group on both fine and gross motor skills. In looking at the number of children with ALL who scored in the clinical range of the different subtests, problems in balance skills were found to be most pronounced at the end of induction therapy. Remarkably, half a year after reinduction therapy, problems with balance had decreased, whereas the number of children with fine motor problems had increased. CONCLUSIONS: A relation between the gross motor problems and vincristine neurotoxicity seems plausible based on a descriptive analysis of the data, but this was not supported statistically. Copyright 1999 Wiley-Liss, Inc.
BACKGROUND: Daily life motor skills of children with acute lymphoblastic leukemia (ALL) were studied during treatment using the Movement Assessment Battery for Children (Movement ABC). In addition, the possible relation with vincristine treatment was investigated. PROCEDURE: Seventeen children treated for ALL, aged 4-12 years, were compared to an age- and sex-matched control group. RESULTS: The leukemia group performed more poorly than the control group on both fine and gross motor skills. In looking at the number of children with ALL who scored in the clinical range of the different subtests, problems in balance skills were found to be most pronounced at the end of induction therapy. Remarkably, half a year after reinduction therapy, problems with balance had decreased, whereas the number of children with fine motor problems had increased. CONCLUSIONS: A relation between the gross motor problems and vincristineneurotoxicity seems plausible based on a descriptive analysis of the data, but this was not supported statistically. Copyright 1999 Wiley-Liss, Inc.
Authors: Stanley H Hung; Anne Rankin; Naznin Virji-Babul; Sheila Pritchard; Christopher Fryer; Kristin L Campbell Journal: Physiother Can Date: 2017 Impact factor: 1.037
Authors: Kari L Bjornard; Laura S Gilchrist; Hiroto Inaba; Barthelemy Diouf; Marilyn J Hockenberry; Nina S Kadan-Lottick; Daniel C Bowers; M Eileen Dolan; Nicole J Ullrich; William E Evans; Kirsten K Ness Journal: Lancet Child Adolesc Health Date: 2018-09-01
Authors: Cheryl L Cox; Liang Zhu; Sue C Kaste; Kumar Srivastava; Linda Barnes; Paul C Nathan; Robert J Wells; Kirsten K Ness Journal: Pediatr Blood Cancer Date: 2017-12-29 Impact factor: 3.167
Authors: Corinna Caroline Winter; Carsten Müller; Jendrik Hardes; Joachim Boos; Georg Gosheger; Dieter Rosenbaum Journal: Support Care Cancer Date: 2011-01-20 Impact factor: 3.603
Authors: Mathieu Decock; Robin De Wilde; Ruth Van der Looven; Catharine Vander Linden Journal: Int J Environ Res Public Health Date: 2022-06-09 Impact factor: 4.614
Authors: Marilyn J Hockenberry; Kevin R Krull; Kathleen C Insel; Lynnette L Harris; Patricia M Gundy; Kristin B Adkins; Alice E Pasvogel; Olga A Taylor; Kari M Koerner; David W Montgomery; Adam K Ross; Adam Hill; Ida M Moore Journal: Oncol Nurs Forum Date: 2015-09 Impact factor: 2.172
Authors: Cheryl L Cox; Michele Montgomery; Kevin C Oeffinger; Wendy Leisenring; Lonnie Zeltzer; John A Whitton; Ann C Mertens; Melissa M Hudson; Leslie L Robison Journal: Cancer Date: 2009-02-01 Impact factor: 6.860